financetom
Business
financetom
/
Business
/
China commerce minister meets Apple's Cook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
China commerce minister meets Apple's Cook
Mar 22, 2024 8:39 PM

SHANGHAI, March 23 (Reuters) - China's commerce

minister, Wang Wentao, met with Apple ( AAPL ) chief executive

Tim Cook on Friday, exchanging views on Apple's ( AAPL ) development in

China, and Sino-U.S. economic and trade relations, the ministry

said.

The meeting came a day after Cook opened Apple's ( AAPL ) newest

store in Shanghai, as the phone maker battles falling iPhone

sales in China and rising competition from domestic rivals such

as Huawei.

Wang said that China-U.S. economic and trade cooperation is

a stabilising force for bilateral relations, and that China is

willing to work with the United States to create a fair, stable

and predictable environment for business cooperation between the

two countries, according to a ministry statement on Saturday.

Cook is expected to attend the China Development Forum in

Beijing next week, a gathering of foreign CEOs with top Chinese

policymakers.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Osisko Development Provides Optimized Feasibility Study Results for Cariboo Gold Project
Update: Osisko Development Provides Optimized Feasibility Study Results for Cariboo Gold Project
May 25, 2025
11:44 AM EDT, 04/28/2025 (MT Newswires) -- (Adds comment and updates shares.) Osisko Development ( ODV ) reported Monday the results of an optimized feasibility study for the Cariboo gold project in British Columbia. The company said the study supports the development of an $881-million mining project producing 190,000 ounces of gold annually over a 10-year mine life The study...
Zentalis Pharmaceuticals Doses 1st Patient in Part 2 of Ovarian Cancer Clinical Trial
Zentalis Pharmaceuticals Doses 1st Patient in Part 2 of Ovarian Cancer Clinical Trial
May 25, 2025
11:41 AM EDT, 04/28/2025 (MT Newswires) -- Zentalis Pharmaceuticals ( ZNTL ) said Monday it has dosed the first patient in part 2 of the phase 2 clinical trial of azenosertib in ovarian cancer patients. The company said it expects to release topline data from part 2 by the end of 2026, adding that a successful trial can support an...
Halozyme Therapeutics Says VYVGART to Treat Rare Autoimmune Disease Receives CHMP Recommendation
Halozyme Therapeutics Says VYVGART to Treat Rare Autoimmune Disease Receives CHMP Recommendation
May 25, 2025
11:41 AM EDT, 04/28/2025 (MT Newswires) -- Halozyme Therapeutics ( HALO ) said Monday its license partner, argenx, received a positive opinion for VYVGART from the European Medicines Agency's Committee for Medicinal Products for Human Use to treat adults with chronic inflammatory demyelinating polyneuropathy. The subcutaneous injection of VYVGART is co-formulated with Halozyme's ENHANZE drug delivery technology. CIDP is a...
Guardant Health Launches Molecular Profiling Cancer Test
Guardant Health Launches Molecular Profiling Cancer Test
May 25, 2025
11:45 AM EDT, 04/28/2025 (MT Newswires) -- Guardant Health ( GH ) said Monday it launched its its molecular profiling test Guardant360 Tissue, which provides a more complete view of cancer. The tumor tissue test incorporates comprehensive multiomics analysis, including DNA, RNA, AI-powered PD-L1 and genome-wide methylation data, the company said. The test is covered by Medicare for eligible patients,...
Copyright 2023-2025 - www.financetom.com All Rights Reserved